Recruiting NA Heart Failure

New treatment option for Heart Failure

Official title Liberal or Restricted Fluid Intake in Patients With Heart Failure

ClinicalTrials.gov ID: NCT05931614

What this study is testing

What it's testing
Heart failure is the most common cause of admission to hospital and is associated with high morbidity and mortality. Treatment options consist of medical- and device treatment and self-care strategies, where fluid restriction has been one of the components in the self-care management of patients with chronic heart failure.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Diagnosed with left ventricual heart failure (HFrEF, HFmEF)
  • Physical, cognitive and linguistic ability to carry out all aspects of the study

You likely can't join if

  • Reversible cause of HF (thyroid disorders, severe anemia, etc.)
  • Hyponatremia at baseline (sodium \<130 mmol/L)
  • eGFR at baseline \<30mL/min/1.73m2
  • Scheduled cardiac surgery, coronary intervention (percutaneous coronary intervention or coronary artery bypass graft surgery) within 3 months
  • Myocardial infarction within 3 months
  • Comorbidity for which fluid restriction or unlimited fluid intake is advised
See the full eligibility criteria
Who can join
  • Diagnosed with left ventricual heart failure (HFrEF, HFmEF)
  • Physical, cognitive and linguistic ability to carry out all aspects of the study
What rules you out
  • Reversible cause of HF (thyroid disorders, severe anemia, etc.)
  • Hyponatremia at baseline (sodium \<130 mmol/L)
  • eGFR at baseline \<30mL/min/1.73m2
  • Scheduled cardiac surgery, coronary intervention (percutaneous coronary intervention or coronary artery bypass graft surgery) within 3 months
  • Myocardial infarction within 3 months
  • Comorbidity for which fluid restriction or unlimited fluid intake is advised
  • Life expectancy \<6 months

The study team makes the final eligibility decision.

Where it's taking place

  • Stockholm, Sweden

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.